We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-9.55%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.91B
AUM Growth
-$872M
Cap. Flow
-$3.53M
Cap. Flow %
-0.05%
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
67
Closed
19

Sector Composition

Rank Sector Weight
1 Financials 22.69%
2 Consumer Discretionary 16.64%
3 Healthcare 14.3%
4 Communication Services 12.68%
5 Consumer Staples 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.6B
$25.5M 0.37%
1,164,423
MRK icon
27
Merck
MRK
$323B
$25.2M 0.36%
345,793
AMGN icon
28
Amgen
AMGN
$210B
$21.6M 0.31%
110,716
BIIB icon
29
Biogen
BIIB
$30.7B
$13.3M 0.19%
44,165
-14,905
-25% -$4.76M
GILD icon
30
Gilead Sciences
GILD
$166B
$13M 0.19%
207,691
-5,413
-3% -$378K
BSX icon
31
Boston Scientific
BSX
$68.8B
$13M 0.19%
367,194
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$124B
$12.2M 0.18%
73,337
-2,006
-3% -$348K
BDX icon
33
Becton Dickinson
BDX
$46.2B
$11.9M 0.17%
54,279
ABBV icon
34
AbbVie
ABBV
$469B
$11.6M 0.17%
125,780
HCA icon
35
HCA Healthcare
HCA
$91.3B
$11.5M 0.17%
92,727
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$11M 0.16%
+298,750
New +$10.8M
CNC icon
37
Centene
CNC
$30.5B
$10.8M 0.16%
187,306
LLY icon
38
Eli Lilly
LLY
$1.08T
$10.6M 0.15%
91,848
CI icon
39
Cigna
CI
$78.5B
$10.2M 0.15%
53,825
+17,102
+47% +$3.57M
AGN
40
DELISTED
Allergan plc
AGN
$10.1M 0.15%
75,890
AMRN
41
Amarin Corp
AMRN
$300M
$8.61M 0.12%
31,643
-2,357
-7% -$859K
HOLX
42
DELISTED
Hologic
HOLX
$8.19M 0.12%
199,328
+66,697
+50% +$2.74M
CELG
43
DELISTED
Celgene Corp
CELG
$8.11M 0.12%
126,550
-247
-0.2% -$18.2K
SHPG
44
DELISTED
Shire pic
SHPG
$7.71M 0.11%
44,321
-34,357
-44% -$6.01M
VTRS icon
45
Viatris
VTRS
$20.8B
$7.05M 0.1%
257,473
EW icon
46
Edwards Lifesciences
EW
$49.1B
$7.04M 0.1%
137,829
-139,350
-50% -$7.05M
BMRN icon
47
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.86M 0.08%
68,851
-6,580
-9% -$626K
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
$5.02M 0.07%
51,600
-14,247
-22% -$1.68M
TSM icon
49
TSMC
TSM
$2T
$4.94M 0.07%
133,749
-24,220
-15% -$922K
NVCR icon
50
NovoCure
NVCR
$1.79B
$4.72M 0.07%
141,094
-23,859
-14% -$872K

Similar funds

C WorldWide Group's Q4 2018 Portfolio in Review

As of Q4 2018, C WorldWide Group held 141 positions worth $6.91B, down 11% from $7.79B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q4 2018 filing shows 10 new, 20 increased, 67 reduced and 19 closed positions. Its largest new stake was American Tower: 2,128,357 shares worth $337M. The largest sale was Citigroup, an estimated $355M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q4 2018 buy was American Tower: 2,128,357 shares worth $337M.
  • C WorldWide Group added most to Procter & Gamble in Q4 2018, an estimated $47.1M increase.
  • C WorldWide Group's biggest Q4 2018 reduction was Visa, cutting an estimated $19.2M.
  • C WorldWide Group fully exited Citigroup in Q4 2018, selling an estimated $355M.
  • C WorldWide Group's ten largest holdings make up 71% of its $6.91B portfolio in Q4 2018.
  • C WorldWide Group opened 10 new positions and closed 19 in Q4 2018.
  • C WorldWide Group's portfolio value fell 11% quarter-over-quarter to $6.91B.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.